Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 421

1.

Quantitative analysis of calf mortality in Great Britain.

Hyde RM, Green MJ, Sherwin VE, Hudson C, Gibbons J, Forshaw T, Vickers M, Down PM.

J Dairy Sci. 2020 Jan 15. pii: S0022-0302(20)30033-3. doi: 10.3168/jds.2019-17383. [Epub ahead of print]

PMID:
31954578
2.

Evaluation of the underlying causes of papilledema in children.

Hyde RA, Mocan MC, Sheth U, Kaufman LM.

Can J Ophthalmol. 2019 Dec;54(6):653-658. doi: 10.1016/j.jcjo.2019.02.007. Epub 2019 Apr 4.

PMID:
31836094
3.

Loss of FBXO9 Enhances Proteasome Activity and Promotes Aggressiveness in Acute Myeloid Leukemia.

Hynes-Smith RW, Swenson SA, Vahle H, Wittorf KJ, Caplan M, Amador C, Hyde RK, Buckley SM.

Cancers (Basel). 2019 Nov 3;11(11). pii: E1717. doi: 10.3390/cancers11111717.

4.

Advanced practice for children and young people: A systematic review with narrative summary.

Hyde R, MacVicar S, Humphrey T.

J Adv Nurs. 2020 Jan;76(1):135-146. doi: 10.1111/jan.14243. Epub 2019 Nov 8. Review.

PMID:
31642083
5.

Spatial-Temporal Cluster Analysis of Childhood Cancer in California.

Francis SS, Enders C, Hyde R, Gao X, Wang R, Ma X, Wiemels JL, Selvin S, Metayer C.

Epidemiology. 2019 Oct 8. doi: 10.1097/EDE.0000000000001121. [Epub ahead of print]

PMID:
31596791
6.

ClustR: A Space-Time Cluster Analysis R Package for Individual-level Data.

Enders C, Hyde RJ, Selvin S, Metayer C, Francis SS.

Epidemiology. 2019 Oct 8. doi: 10.1097/EDE.0000000000001122. [Epub ahead of print]

PMID:
31596789
7.

Increased Clinical and Economic Burden Associated With Peripheral Intravenous Catheter-Related Complications: Analysis of a US Hospital Discharge Database.

Lim S, Gangoli G, Adams E, Hyde R, Broder MS, Chang E, Reddy SR, Tarbox MH, Bentley T, Ovington L, Danker W 3rd.

Inquiry. 2019 Jan-Dec;56:46958019875562. doi: 10.1177/0046958019875562.

8.

A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis.

Pellegrini F, Copetti M, Bovis F, Cheng D, Hyde R, de Moor C, Kieseier BC, Sormani MP.

Mult Scler. 2019 May 30:1352458519849513. doi: 10.1177/1352458519849513. [Epub ahead of print]

PMID:
31144577
9.

Pre- and Early Pregnancy Onset Depression and Subsequent Rate of Gestational Weight Gain.

Badon SE, Hedderson MM, Hyde RJ, Quesenberry CP, Avalos LA.

J Womens Health (Larchmt). 2019 Sep;28(9):1237-1245. doi: 10.1089/jwh.2018.7497. Epub 2019 May 7.

PMID:
31063018
10.

Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia.

Wang Y, Xie Y, Williams J, Hang Y, Richter L, Becker M, Amador C, Oupický D, Hyde RK.

Cancer Gene Ther. 2019 Apr 26. doi: 10.1038/s41417-019-0095-9. [Epub ahead of print]

PMID:
31028289
11.

CDK7 is a component of the integrated stress response regulating SNAT2 (SLC38A2)/System A adaptation in response to cellular amino acid deprivation.

Stretton C, Lipina C, Hyde R, Cwiklinski E, Hoffmann TM, Taylor PM, Hundal HS.

Biochim Biophys Acta Mol Cell Res. 2019 Jun;1866(6):978-991. doi: 10.1016/j.bbamcr.2019.03.002. Epub 2019 Mar 8.

12.

HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.

Richter LE, Wang Y, Becker ME, Coburn RA, Williams JT, Amador C, Hyde RK.

Mol Cancer Res. 2019 Jun;17(6):1241-1252. doi: 10.1158/1541-7786.MCR-18-0922. Epub 2019 Feb 27.

PMID:
30814129
13.

Late detachment of Descemet's membrane after penetrating keratoplasty for pellucid marginal degeneration.

Lin J, Hassanaly S, Hyde RA, Brown J, Yoon D, Yu CQ.

Am J Ophthalmol Case Rep. 2018 Dec 18;13:151-153. doi: 10.1016/j.ajoc.2018.12.016. eCollection 2019 Mar.

14.

IL1RL1 is dynamically expressed on Cbfb-MYH11+ leukemia stem cells and promotes cell survival.

Wang Y, Richter L, Becker M, Amador C, Hyde RK.

Sci Rep. 2019 Feb 11;9(1):1729. doi: 10.1038/s41598-018-38408-3.

15.

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study.

Nguyen AL, Havrdova EK, Horakova D, Izquierdo G, Kalincik T, van der Walt A, Terzi M, Alroughani R, Duquette P, Girard M, Prat A, Boz C, Sola P, Ferraro D, Lugaresi A, Lechner-Scott J, Barnett M, Grand'Maison F, Grammond P, Ramo-Tello C, Turkoglu R, McCombe P, Pucci E, Trojano M, Granella F, Spitaleri D, Van Pesch V, Soysal A, Oreja-Guevara C, Verheul F, Vucic S, Hodgkinson S, Slee M, Ampapa R, Prevost J, Menoyo JLS, Skibina O, Solaro C, Olascoaga J, Shaw C, Madsen KG, Naidoo K, Hyde R, Butzkueven H, Jokubaitis V; MSBase Study Group.

Mult Scler Relat Disord. 2019 Feb;28:235-243. doi: 10.1016/j.msard.2019.01.003. Epub 2019 Jan 3.

PMID:
30623864
16.

Removal of copper from cattle footbath wastewater with layered double hydroxide adsorbents as a route to antimicrobial resistance mitigation on dairy farms.

Williams O, Clark I, Gomes RL, Perehinec T, Hobman JL, Stekel DJ, Hyde R, Dodds C, Lester E.

Sci Total Environ. 2019 Mar 10;655:1139-1149. doi: 10.1016/j.scitotenv.2018.11.330. Epub 2018 Nov 22.

17.

Letter to the editor.

Valentin R, Hyde R, Gomez-Manjarres D, Patel DC.

Respir Med. 2019 Mar;149:42. doi: 10.1016/j.rmed.2018.10.011. Epub 2018 Oct 19. No abstract available.

PMID:
30528974
18.

Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry.

Braune S, Grimm S, van Hövell P, Freudensprung U, Pellegrini F, Hyde R, Bergmann A; NTD Study Group.

J Neurol. 2018 Dec;265(12):2980-2992. doi: 10.1007/s00415-018-9083-5. Epub 2018 Oct 16.

19.

Primary antiphospholipid syndrome associated Liebman-Sachs endocarditis leading to diffuse alveolar hemorrhage: A case report.

Hyde R, Runnstrom M, Anderson A, Riley L, Ataya A.

Respir Med Case Rep. 2018 Aug 24;25:181-183. doi: 10.1016/j.rmcr.2018.08.018. eCollection 2018.

20.

Pasteurella multocida prosthetic joint infection.

Runnstrom M, Hyde R, Shah K.

IDCases. 2018 Jul 24;13:e00429. doi: 10.1016/j.idcr.2018.e00429. eCollection 2018. No abstract available.

21.

Using bioreactors to study the effects of drugs on the human microbiota.

Guzman-Rodriguez M, McDonald JAK, Hyde R, Allen-Vercoe E, Claud EC, Sheth PM, Petrof EO.

Methods. 2018 Oct 1;149:31-41. doi: 10.1016/j.ymeth.2018.08.003. Epub 2018 Aug 11. Review.

PMID:
30102990
22.

Solitary fibrous tumor of the orbit with growth during pregnancy: a case report.

Hyde RA, Liu Y, Aakalu VK, Setabutr P.

Orbit. 2019 Jun;38(3):256-258. doi: 10.1080/01676830.2018.1474930. Epub 2018 May 21.

PMID:
29781760
23.

A 77-Year-Old Woman With Acute Shortness of Breath and Chest Pain.

Hyde R, Chung J, Chertoff J, Alnuaimat H, Ataya A.

Chest. 2018 Apr;153(4):e89-e91. doi: 10.1016/j.chest.2017.09.007.

PMID:
29626975
24.

Effects of Sodium and Amino Acid Substrate Availability upon the Expression and Stability of the SNAT2 (SLC38A2) Amino Acid Transporter.

Hoffmann TM, Cwiklinski E, Shah DS, Stretton C, Hyde R, Taylor PM, Hundal HS.

Front Pharmacol. 2018 Feb 7;9:63. doi: 10.3389/fphar.2018.00063. eCollection 2018.

25.

COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.

Lim JI, Machen L, Arteaga A, Karas FI, Hyde R, Cao D, Niec M, Vajaranant TS, Cortina MS.

Retina. 2018 Sep;38 Suppl 1:S125-S133. doi: 10.1097/IAE.0000000000002036.

26.

Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis.

Graeber SY, Dopfer C, Naehrlich L, Gyulumyan L, Scheuermann H, Hirtz S, Wege S, Mairbäurl H, Dorda M, Hyde R, Bagheri-Hanson A, Rueckes-Nilges C, Fischer S, Mall MA, Tümmler B.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1433-1442. doi: 10.1164/rccm.201710-1983OC.

PMID:
29327948
27.

Quantitative analysis of antimicrobial use on British dairy farms.

Hyde RM, Remnant JG, Bradley AJ, Breen JE, Hudson CD, Davies PL, Clarke T, Critchell Y, Hylands M, Linton E, Wood E, Green MJ.

Vet Rec. 2017 Dec 23;181(25):683. doi: 10.1136/vr.104614. Epub 2017 Dec 20.

PMID:
29263292
28.

An advanced nurse practitioner service for neonates, children and young people.

Hyde R.

Nurs Child Young People. 2017 Oct 10;29(8):36-41. doi: 10.7748/ncyp.2017.e938.

PMID:
29115771
29.

Quantitative analysis of antibiotic usage in British sheep flocks.

Davies P, Remnant JG, Green MJ, Gascoigne E, Gibbon N, Hyde R, Porteous JR, Schubert K, Lovatt F, Corbishley A.

Vet Rec. 2017 Nov 11;181(19):511. doi: 10.1136/vr.104501. Epub 2017 Oct 19.

PMID:
29051311
30.

Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11.

Zhen T, Kwon EM, Zhao L, Hsu J, Hyde RK, Lu Y, Alemu L, Speck NA, Liu PP.

Blood. 2017 Nov 30;130(22):2431-2442. doi: 10.1182/blood-2017-04-780106. Epub 2017 Oct 10.

31.
32.

Photopolymerization-based synthesis of iron oxide nanoparticle embedded PNIPAM nanogels for biomedical applications.

Denmark DJ, Hyde RH, Gladney C, Phan MH, Bisht KS, Srikanth H, Mukherjee P, Witanachchi S.

Drug Deliv. 2017 Nov;24(1):1317-1324. doi: 10.1080/10717544.2017.1373164.

PMID:
28906151
33.

Sponsorship bias and quality of randomised controlled trials in veterinary medicine.

Wareham KJ, Hyde RM, Grindlay D, Brennan ML, Dean RS.

BMC Vet Res. 2017 Aug 14;13(1):234. doi: 10.1186/s12917-017-1146-9.

34.

RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.

Hyde RK, Liu P, Friedman AD.

Adv Exp Med Biol. 2017;962:265-282. doi: 10.1007/978-981-10-3233-2_17. Review.

PMID:
28299663
35.

Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses.

Giovannoni G, Cutter G, Sormani MP, Belachew S, Hyde R, Koendgen H, Knappertz V, Tomic D, Leppert D, Herndon R, Wheeler-Kingshott CAM, Ciccarelli O, Selwood D, di Cantogno EV, Ben-Amor AF, Matthews P, Carassiti D, Baker D, Schmierer K.

Mult Scler Relat Disord. 2017 Feb;12:70-78. doi: 10.1016/j.msard.2017.01.007. Epub 2017 Jan 17. Review.

PMID:
28283111
36.

Tool to measure antimicrobial use on farms.

Hyde R, Green M, Remnant J, Down P, Huxley J, Davies P, Hudson C, Breen J.

Vet Rec. 2017 Feb 18;180(7):183. doi: 10.1136/vr.j823. No abstract available.

PMID:
28213427
37.

Mixed diagnosis for Serbian health system.

Hyde R.

Lancet. 2016 Dec 3;388(10061):2729-2730. doi: 10.1016/S0140-6736(16)32460-6. Epub 2016 Dec 2. No abstract available.

PMID:
27924768
38.

Emergency Medicine Resident Assessment of the Emergency Ultrasound Milestones and Current Training Recommendations.

Stolz LA, Stolz U, Fields JM, Saul T, Secko M, Flannigan MJ, Sheele JM, Rifenburg RP, Weekes AJ, Josephson EB, Bedolla J, Resop DM, Dela Cruz J, Boysen-Osborn M, Caffery T, Derr C, Bengiamin R, Chiricolo G, Backlund B, Heer J, Hyde RJ, Adhikari S.

Acad Emerg Med. 2017 Mar;24(3):353-361. doi: 10.1111/acem.13113. Epub 2017 Feb 18.

39.

Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.

Richter L, Wang Y, Hyde RK.

Oncotarget. 2016 Oct 4;7(40):66255-66266. doi: 10.18632/oncotarget.11357. Review.

40.

Refugees need health cards, say German doctors.

Hyde R.

Lancet. 2016 Aug 13;388(10045):646-8. doi: 10.1016/S0140-6736(16)31346-0. No abstract available.

PMID:
27533428
41.

Primary Baerveldt Shunt Implantation: Outcomes and Complications.

Namavari A, Hyde RA, Wang D, Vajaranant TS, Aref AA.

Ophthalmol Ther. 2016 Dec;5(2):253-262. Epub 2016 Jul 25.

42.

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

Spelman T, Kalincik T, Jokubaitis V, Zhang A, Pellegrini F, Wiendl H, Belachew S, Hyde R, Verheul F, Lugaresi A, Havrdová E, Horáková D, Grammond P, Duquette P, Prat A, Iuliano G, Terzi M, Izquierdo G, Hupperts RM, Boz C, Pucci E, Giuliani G, Sola P, Spitaleri DL, Lechner-Scott J, Bergamaschi R, Grand'Maison F, Granella F, Kappos L, Trojano M, Butzkueven H.

Neurol Clin Pract. 2016 Apr;6(2):102-115.

43.

Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci.

Kachuri L, Amos CI, McKay JD, Johansson M, Vineis P, Bueno-de-Mesquita HB, Boutron-Ruault MC, Johansson M, Quirós JR, Sieri S, Travis RC, Weiderpass E, Le Marchand L, Henderson BE, Wilkens L, Goodman GE, Chen C, Doherty JA, Christiani DC, Wei Y, Su L, Tworoger S, Zhang X, Kraft P, Zaridze D, Field JK, Marcus MW, Davies MPA, Hyde R, Caporaso NE, Landi MT, Severi G, Giles GG, Liu G, McLaughlin JR, Li Y, Xiao X, Fehringer G, Zong X, Denroche RE, Zuzarte PC, McPherson JD, Brennan P, Hung RJ.

Carcinogenesis. 2016 Jan;37(1):96-105. doi: 10.1093/carcin/bgv165. Epub 2015 Nov 20.

44.

Dynamics of robust pattern separability in the hippocampal dentate gyrus.

Zylberberg J, Hyde RA, Strowbridge BW.

Hippocampus. 2016 May;26(5):623-32. doi: 10.1002/hipo.22546. Epub 2015 Nov 5.

45.

A P450 fusion library of heme domains from Rhodococcus jostii RHA1 and its evaluation for the biotransformation of drug molecules.

Kulig JK, Spandolf C, Hyde R, Ruzzini AC, Eltis LD, Grönberg G, Hayes MA, Grogan G.

Bioorg Med Chem. 2015 Sep 1;23(17):5603-9. doi: 10.1016/j.bmc.2015.07.025. Epub 2015 Jul 21.

PMID:
26234905
46.

Comparative efficacy of switching to natalizumab in active multiple sclerosis.

Spelman T, Kalincik T, Zhang A, Pellegrini F, Wiendl H, Kappos L, Tsvetkova L, Belachew S, Hyde R, Verheul F, Grand-Maison F, Izquierdo G, Grammond P, Duquette P, Lugaresi A, Lechner-Scott J, Oreja-Guevara C, Hupperts R, Petersen T, Barnett M, Trojano M, Butzkueven H.

Ann Clin Transl Neurol. 2015 Apr;2(4):373-87. doi: 10.1002/acn3.180. Epub 2015 Feb 27.

47.

Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.

Kinkel RP, Simon JH, O'Connor P, Hyde R, Pace A.

Mult Scler Relat Disord. 2014 Nov;3(6):712-9. doi: 10.1016/j.msard.2014.08.003. Epub 2014 Aug 27.

PMID:
25891550
48.

Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.

Hyde RK, Zhao L, Alemu L, Liu PP.

Leukemia. 2015 Aug;29(8):1771-8. doi: 10.1038/leu.2015.58. Epub 2015 Mar 6.

49.

Ten-year follow-up of the 'minimal MRI lesion' subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial.

Simon JH, Kinkel RP, Kollman C, O'Connor P, Fisher E, You X, Hyde R; CHAMPIONS Investigators Group.

Mult Scler. 2015 Apr;21(4):415-22. doi: 10.1177/1352458514547407. Epub 2014 Oct 24.

PMID:
25344370
50.

Unique volatolomic signatures of TP53 and KRAS in lung cells.

Davies MP, Barash O, Jeries R, Peled N, Ilouze M, Hyde R, Marcus MW, Field JK, Haick H.

Br J Cancer. 2014 Sep 9;111(6):1213-21. doi: 10.1038/bjc.2014.411. Epub 2014 Jul 22.

Supplemental Content

Support Center